FDA Investigator Stephen L Beekman

Stephen L Beekman has conducted inspections on 71 sites in 1 countries as of 09 Jan 2006. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
71
Last Inspection Date:
09 Jan 2006
Investigator Role:
FDA Investigator
Redica ID:
100007175
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Stephen L Beekman:
Adaris Mas Rivera, Ademola O Daramola, Adrian Rodriguez, Akbar J Zaidi, Alan P Kurtzberg, Alcee M Tavarez, Andrea A Branche, Anh M Lac, Aqualia L Nelson, Blondell Hill, Blondell W Johnson, Brian J Ryan, Camerson E Moore, Charles B Steinmiller, Charles D Brown, Christopher D Rush, Christopher N Tran, Connie L Hannon Rabel, Cynthia A Harris, MD, RN, Dallas E Gilbreath Jr, Damaris Y Hernandez, Daniel J Lahar, Darla J Christopher, David M Beltran, Dennis R Hudson, Diane L Raccasi, Edward D Edmiston, Edwin Ramos, Elisa M Fleming, Elizabeth D Connell, Ernest Serna, III, Frans E Mercado, Glasgow Glasgow, Grant L Davis, Gregory A Holt, Gretchen M Laws, Gwendolyn F Anderson, H Ljamilla Selby, Habacuc V Barrera, Hala L Selby, Iris C Macinnes, J Elkins, Jamie M Bumpas, Janete F Guardia, Janice M Hickok, Jeffrey R Wooley, Jennifer D Young, Jennifer Hua, Jeremy W Rotton, Joanne M Schlossin, Jodi M Gatica, Joel D Martinez, Johann M Fitch, José E Meléndez, Jose Martinez, Jr, Joseph E Duran, Karen C Daugherty, Kari M Johansen, Kari M Laynor, Karlton T Watson, Kathleen Chmura Shaffer, Kayla R Deatherage, Kenitra D Hewitt, Kevin T Nguyen, L Grant, Lance Sindo, CIH, CQA, RS, Latorie S Jones, Lauren E Skokan, Leighton Kn Gai, Lisa M Puttonen, Lisa M Yoder, Lisa R Jennings, Lisa R Whitt, Lloyd D Payne, Lorie S Hannappel, Lourdes R Genera, Lowell R Oates, Lucas B Leake, Maotang Zhou, PhD, Marc R Dickens, Margaret M Annes, Mariana F Baxter, Martha S Baldwin, Martrice A Packer, Massoud Motamed, Matthew R Maddox, Michelle A Krayer, Monique Rac Lester, Monique S Frazier, Nancy S Henley, Navista C Bolton, Nimmy Mathews, Oluwasefunm Agbanigo, P John Kamthong, Patrice S Hall, Patty P Kaewussdangkul, Pauline N Logan, Payne, Philip M Steele, PhD, Phillip D Waldron, Pitman, Ralph H Vocque, Rebecca Co Bryan, Rebecca Rodriguez, Rendall E Barfoot, Rhonda L Dash, Robert D Tollefsen, Robert M Tillman, Robert T Harris, Rodney L Tinzie, Ronda Rloyd Jones, Roy Baby, Saijal P Naik, Sakineh Walther, Saleem A Akhtar, Samuel A Hamblin, Sandy J Ziegler, Sarah L Fredric, Scott R Nichols, PhD, Scott T Ballard, Sean M Cheney, Seri L Essary, Sha'tina R Alridge, Shanna N Purdy, Shannon A Lowe, Shawn E Larson, Shelby N Turner, Sherrie L Krolczyk, Sina Shojaee, Staci G Mcallister, Stephen D Brown, Suzanne N Vallez, Tamera H Hunt, Tamil Arasu, PhD, Tara A Gray, Theresa Kirkham (NMI), Thomas J Arista, Timothy B Webb, Timothy H Vo, Toby Vern H Hill, Torrance J Slayton, Travis M Beard, Tricia S Martinez, Trina K Vick, Unnee Ranjan, Vivian Garcia

Stephen L Beekman's Documents

Publish Date Document Type Title
February, 2003 EIR Alcon Research, LLC - EIR, 2003-02-21
September, 2002 EIR Airgas Mid South, Inc - EIR, 2002-09-25
February, 2004 FDA 483 Allergan Sales, LLC - Form 483, 2004-02-25
August, 2003 FDA 483 QuVa Pharma, Inc. - Form 483, 2003-08-22
January, 2003 EIR Aurorium LLC - EIR, 2003-01-28
September, 2002 FDA 483 Airgas Mid South, Inc - Form 483, 2002-09-25
July, 2003 FDA 483 Bio-Derm Laboratories, Inc - Form 483, 2003-07-28
January, 2005 EIR Allergan Sales, LLC - EIR, 2005-01-28
February, 2000 EIR The Dow Chemical Company - EIR, 2000-02-03
April, 2004 FDA 483 Central Admixture Pharmacy Services, Inc - Form 483, 2004-04-16
February, 2004 EIR Allergan Sales, LLC - EIR, 2004-02-25
May, 2002 EIR Figaro Co, Inc - EIR, 2002-05-24
January, 2005 FDA 483 Allergan Sales, LLC - Form 483, 2005-01-28
January, 2005 FDA 483 Response Allergan Sales, LLC - Form 483R, 2005-02-18
February, 2003 FDA 483 Alcon Research, LLC - Form 483, 2003-02-21
January, 2003 FDA 483 Aurorium LLC - Form 483, 2003-01-28
February, 2004 FDA 483 Response Allergan Sales, LLC - Form 483R, 2004-03-31
May, 2003 FDA 483 Garland Welding Supply Co, Inc - Form 483, 2003-05-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more